| PERIOD ENDING | 4-Apr-09 | 3-Jan-09 | 27-Sep-08 | 28-Jun-08 | | Total Revenue | 2,526,000 | 3,606,000 | 3,203,000 | 3,919,000 | | Cost of Revenue | 1,999,000 | 2,817,000 | 2,398,000 | 2,948,000 | | | Gross Profit | 527,000 | 789,000 | 805,000 | 971,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 346,000 | 412,000 | 359,000 | 439,000 | | Non Recurring | (18,000) | 425,000 | 101,000 |
-
| | Others | 76,000 |
-
|
-
| (27,000) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 123,000 | (48,000) | 345,000 | 559,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (234,000) | 67,000 | (67,000) | | Earnings Before Interest And Taxes | 123,000 | (282,000) | 412,000 | 492,000 | | Interest Expense | 82,000 | 114,000 | 102,000 | 101,000 | | Income Before Tax | 41,000 | (396,000) | 310,000 | 391,000 | | Income Tax Expense | (2,000) | (48,000) | 115,000 | 130,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 43,000 | (348,000) | 195,000 | 261,000 | | | Non-recurring Events | | Discontinued Operations | 43,000 | 139,000 | 11,000 | (3,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 86,000 | (209,000) | 206,000 | 258,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $86,000 | ($209,000) | $206,000 | $258,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
